The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Postdoctoral Researcher position at Growth Factors Laboratory”
Application deadline: 01.03.2023
Number of vacancies: 1
VHIO offers a position for a postdoctoral researcher within the Growth Factors Research Laboratory led by ICREA Research Professor Joaquin Arribas.
The group is focused on cancer biology research with a clear translational perspective. We use patient-derived experimental models and Humanized PDX models, to study mechanisms of resistance to current therapies, and develop novel and more effective therapies, particularly immunotherapies. Additionally, we use these and other models to investigate the role of cellular senescence in cancer progression and treatment.
We are seeking a highly qualified and experienced candidate with at least two years of experience as a postdoctoral researcher in cancer research, demonstrated by publications in high-impact journals. The ideal candidate will have a track record of working independently and also be able to effectively contribute to and collaborate with the team.
- Bilal, F. et al. “The transcription factor Slug uncouples pancreatic cancer progression from the Raf-Mek1/2-Erk1/2 pathway.” Cancer Research 81 (2021): 3849. doi: 10.1158/0008-5472.CAN-20-4263.
- Arenas, E. J. et al. “Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation.” Nature Communications 12 (2021): 1237. doi: 10.1038/s41467-021-21445-4.
- Martínez-Sabadell, A., Arenas, E. J., and Arribas, J. “IFN-g signaling in natural and therapy-induced anti-tumor responses.” Clinical Cancer Research7 (2022): 1243-1249. doi: 10.1158/1078-0432.CCR-21-3226.
- Cortés, J. et al. “Enhancing global access to cancer medicines.” CA Cancer Journal for Clinicians 70 (2020): 105-124. doi: 10.3322/caac.21597.
- Rius Ruiz, I. et al. “p95HER2-T cell bispecific antibody for breast cancer treatment.” Science Translational Medicine 461 (2018): eaat1445. doi: 10.1126/scitranslmed.aat1445.
Education and qualifications
- PhD in Biomedicine or similar
Experience and knowledge
- Cancer biology research techniques.
- Scientific Articles publication.
- Grant application
- Mentoring of students
Main responsibilities and duties
- Conduct experiments and data analysis
- Participate in the writing and presentation of scientific papers and funding applications.
- Collaborate with the coordination of international grants
- Mentor graduate students and other junior researchers
- Collaborate at organization tasks in the lab.
- Start: Immediately
Application: Applicants should send a full Curriculum Vitae and a cover letter to firstname.lastname@example.org and email@example.com.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: https://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.